Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grail
MedTech
Illumina gets go-ahead from EU to part ways with Grail
The DNA sequencing giant still has the freedom to choose between selling the cancer blood test developer outright or pursuing an independent spinout.
Conor Hale
Apr 12, 2024 10:11am
Illumina tops quarterly estimates as it preps to let go of Grail
Jan 9, 2024 5:03pm
Illumina sets a date to divest Grail
Dec 18, 2023 11:12am
Illumina cuts 2023 sales projections as new CEO takes helm
Nov 10, 2023 10:38am
Icahn sues Illumina and its board over Grail deal fallout
Oct 24, 2023 3:15pm
EU orders Illumina to split from Grail as penance for $8B deal
Oct 12, 2023 11:14am